These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 34322391)

  • 1. Identification and Validation of a Novel Immune-Related lncRNA Signature for Bladder Cancer.
    Hua S; Xie Z; Wang W; Wan Z; Chen M; Zhao S; Jiang J
    Front Oncol; 2021; 11():704946. PubMed ID: 34322391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune-Related lncRNA to Construct Novel Signature and Predict the Immune Landscape of Human Hepatocellular Carcinoma.
    Hong W; Liang L; Gu Y; Qi Z; Qiu H; Yang X; Zeng W; Ma L; Xie J
    Mol Ther Nucleic Acids; 2020 Dec; 22():937-947. PubMed ID: 33251044
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Immune-Related lncRNA Pairs and Construction and Validation of a New Prognostic Signature of Colon Cancer.
    Xu M; Li Q; Zhang J; Xie H
    Can J Gastroenterol Hepatol; 2022; 2022():5827544. PubMed ID: 35399646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Construction of a Novel Lung Adenocarcinoma Immune-Related lncRNA Pair Signature.
    Qi X; Chen G; Chen Z; Li J; Chen W; Lin J; Lin L
    Int J Gen Med; 2021; 14():4279-4289. PubMed ID: 34421308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction of a Novel Immune-Related lncRNA Pair Signature with Prognostic Significance for Kidney Clear Cell Renal Cell Carcinoma.
    Sun JX; Xia QD; Liu CQ; Xu JZ; Xun Y; Lu JL; Hu J; Wang SG
    Dis Markers; 2021; 2021():8800358. PubMed ID: 34512816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Using Immune-Related Long Non-coding Ribonucleic Acids to Develop a Novel Prognosis Signature and Predict the Immune Landscape of Colon Cancer.
    Wang X; Chen K; Wang Z; Xu Y; Dai L; Bai T; Chen B; Yang W; Chen W
    Front Cell Dev Biol; 2021; 9():750709. PubMed ID: 34660608
    [No Abstract]   [Full Text] [Related]  

  • 7. Construction of a novel immune-related lncRNA signature and its potential to predict the immune status of patients with hepatocellular carcinoma.
    Deng M; Lin JB; Zhao RC; Li SH; Lin WP; Zou JW; Wei W; Guo RP
    BMC Cancer; 2021 Dec; 21(1):1347. PubMed ID: 34923955
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel Prognosis and Therapeutic Response Model of Immune-Related lncRNA Pairs in Clear Cell Renal Cell Carcinoma.
    Wang G; Liu P; Li J; Jin K; Zheng X; Xie L
    Vaccines (Basel); 2022 Jul; 10(7):. PubMed ID: 35891325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predicting the immune landscape of invasive breast carcinoma based on the novel signature of immune-related lncRNA.
    Shen S; Chen X; Hu X; Huo J; Luo L; Zhou X
    Cancer Med; 2021 Sep; 10(18):6561-6575. PubMed ID: 34378851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of Immune-Related Long Non-coding RNAs to Construct a Novel Signature and Predict the Prognosis and Immune Landscape of Soft Tissue Sarcoma.
    Lin Z; Pang K; Li H; Zhang X; Wan J; Zheng T; Liu T; Peng W
    Front Cell Dev Biol; 2021; 9():709241. PubMed ID: 34631703
    [No Abstract]   [Full Text] [Related]  

  • 11. Immune-Related lncRNA Signature for Predicting the Immune Landscape of Head and Neck Squamous Cell Carcinoma.
    Yin J; Li X; Lv C; He X; Luo X; Li S; Hu W
    Front Mol Biosci; 2021; 8():689224. PubMed ID: 34327215
    [No Abstract]   [Full Text] [Related]  

  • 12. Predicting the Survival and Immune Landscape of Colorectal Cancer Patients Using an Immune-Related lncRNA Pair Model.
    Ma C; Zhang X; Zhao X; Zhang N; Zhou S; Zhang Y; Li P
    Front Genet; 2021; 12():690530. PubMed ID: 34552614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune-related lncRNA pairs as novel signature to predict prognosis and immune landscape in melanoma patients.
    Li Z; Wei J; Zheng H; Gan X; Song M; Zhang Y; Jin Y
    Medicine (Baltimore); 2022 Jan; 101(1):e28531. PubMed ID: 35029920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Novel Prognostic Signature of Immune-Related Long Noncoding RNA Pairs for Tumor-Infiltrating Immune Cells and Drug Susceptibility in Breast Cancer.
    Li S; Sun X; Li J; Zheng A; Cao Y; Guo Y; Jin F
    DNA Cell Biol; 2022 Feb; 41(2):103-115. PubMed ID: 34762509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction of a new immune-related lncRNA model and prediction of treatment and survival prognosis of human colon cancer.
    Liu S; Peng X; Wu X; Bu F; Yu Z; Zhu J; Luo C; Zhang W; Liu J; Huang J
    World J Surg Oncol; 2022 Mar; 20(1):71. PubMed ID: 35249533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel immune-related lncRNA signature predicts the prognosis and immune landscape in ccRCC.
    Dai L; Pan D; Jin J; Lv W
    Aging (Albany NY); 2024 Mar; 16(6):5149-5162. PubMed ID: 38484738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Applying immune-related lncRNA pairs to construct a prognostic signature and predict the immune landscape of stomach adenocarcinoma.
    Wang Y; Zhang X; Dai X; He D
    Expert Rev Anticancer Ther; 2021 Oct; 21(10):1161-1170. PubMed ID: 34319826
    [No Abstract]   [Full Text] [Related]  

  • 18. Immune-Related lncRNAs Pairs to Construct a Novel Signature for Predicting Prognosis in Gastric Cancer.
    Bao T; Wang Z; Xu J
    Front Surg; 2022; 9():807778. PubMed ID: 35402492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune-Related lncRNA Pairs as Prognostic Signature and Immune-Landscape Predictor in Lung Adenocarcinoma.
    Yin Z; Zhou M; Liao T; Xu J; Fan J; Deng J; Jin Y
    Front Oncol; 2021; 11():673567. PubMed ID: 35083132
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Novel Signature Constructed by Immune-Related LncRNA Predicts the Immune Landscape of Colorectal Cancer.
    Sun M; Zhang T; Wang Y; Huang W; Xia L
    Front Genet; 2021; 12():695130. PubMed ID: 34434220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.